Interferon activated gene 204 protects against bone loss in experimental periodontitis

Background Periodontal destruction can be the result of different known and yet‐to‐be‐discovered biological pathways. Recent human genetic association studies have implicated interferon‐gamma inducible protein 16 (IFI16) and absent in melanoma 2 (AIM2) with high periodontal interleukin (IL)‐1β level...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of periodontology (1970) 2022-09, Vol.93 (9), p.1366-1377
Hauptverfasser: Swanson, Karen V., Girnary, Mustafa, Alves, Tomaz, Ting, Jenny PY, Divaris, Kimon, Beck, Jim, Pucinelli, Carolina Maschietto, da Silva, Raquel Assed Bezerra, Uyan, Dilek, Wilson, Justin E., Seaman, William T., Webster‐Cyriaque, Jennifer, Vias, Nishma, Jiao, Yizu, Cantley, Lloyd, Marlier, Arnaud, Arnold, Roland R., Marchesan, Julie T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1377
container_issue 9
container_start_page 1366
container_title Journal of periodontology (1970)
container_volume 93
creator Swanson, Karen V.
Girnary, Mustafa
Alves, Tomaz
Ting, Jenny PY
Divaris, Kimon
Beck, Jim
Pucinelli, Carolina Maschietto
da Silva, Raquel Assed Bezerra
Uyan, Dilek
Wilson, Justin E.
Seaman, William T.
Webster‐Cyriaque, Jennifer
Vias, Nishma
Jiao, Yizu
Cantley, Lloyd
Marlier, Arnaud
Arnold, Roland R.
Marchesan, Julie T.
description Background Periodontal destruction can be the result of different known and yet‐to‐be‐discovered biological pathways. Recent human genetic association studies have implicated interferon‐gamma inducible protein 16 (IFI16) and absent in melanoma 2 (AIM2) with high periodontal interleukin (IL)‐1β levels and more destructive disease, but mechanistic evidence is lacking. Here, we sought to experimentally validate these observational associations and better understand IFI16 and AIM2's roles in periodontitis. Methods Periodontitis was induced in Ifi204–/– (IFI16 murine homolog) and Aim2–/– mice using the ligature model. Chimeric mice were created to identify the main source cells of Ifi204 in the periodontium. IFI16‐silenced human endothelial cells were treated with periodontal pathogens in vitro. Periodontal tissues from Ifi204–/– mice were evaluated for alveolar bone (micro‐CT), cell inflammatory infiltration (MPO+ staining), Il1b (qRT‐PCR), and osteoclast numbers (cathepsin K+ staining). Results Ifi204‐deficient mice> exhibited >20% higher alveolar bone loss than wild‐type (WT) (P 
doi_str_mv 10.1002/JPER.21-0668
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9489626</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2649252399</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3905-1b0039354e345742a8f3882810e8daec3ba53c3cdddcfd6b60546bc068b534fc3</originalsourceid><addsrcrecordid>eNp9kUFvVCEUhYmxsWN159qwdNHXAheYx8bENNXWNGlj1C3h8e4bMW9gBKbafy_TqY1uXMHN-XI43EPIK85OOGPi9OPN-acTwTumdf-ELLiR0IFesqdk0WTRgTTikDwv5XsbuQT2jByCkkzKpVyQr5exYp4wp0idr-HWVRzpCiNSwSTd5FTR10LdyoVYKh1SU-ZUCg2R4q8N5rDGWN1Md9c0plhDDeUFOZjcXPDlw3lEvrw__3x20V1df7g8e3fVeTBMdXxgDExLgyDVUgrXT9D3oucM-9Ghh8Ep8ODHcfTTqAfNlNSDZ7ofFMjJwxF5u_fdbIc1jr5FyW62m5bK5TubXLD_KjF8s6t0a43sjRa6Gbx5MMjpxxZLtetQPM6zi5i2xQrd1qcEGNPQ4z3qc_t_xunxGc7srgq7q8IKbndVNPz139Ee4T-7bwDsgZ9hxrv_mt0PnBml4Dd03pWL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2649252399</pqid></control><display><type>article</type><title>Interferon activated gene 204 protects against bone loss in experimental periodontitis</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Swanson, Karen V. ; Girnary, Mustafa ; Alves, Tomaz ; Ting, Jenny PY ; Divaris, Kimon ; Beck, Jim ; Pucinelli, Carolina Maschietto ; da Silva, Raquel Assed Bezerra ; Uyan, Dilek ; Wilson, Justin E. ; Seaman, William T. ; Webster‐Cyriaque, Jennifer ; Vias, Nishma ; Jiao, Yizu ; Cantley, Lloyd ; Marlier, Arnaud ; Arnold, Roland R. ; Marchesan, Julie T.</creator><creatorcontrib>Swanson, Karen V. ; Girnary, Mustafa ; Alves, Tomaz ; Ting, Jenny PY ; Divaris, Kimon ; Beck, Jim ; Pucinelli, Carolina Maschietto ; da Silva, Raquel Assed Bezerra ; Uyan, Dilek ; Wilson, Justin E. ; Seaman, William T. ; Webster‐Cyriaque, Jennifer ; Vias, Nishma ; Jiao, Yizu ; Cantley, Lloyd ; Marlier, Arnaud ; Arnold, Roland R. ; Marchesan, Julie T.</creatorcontrib><description>Background Periodontal destruction can be the result of different known and yet‐to‐be‐discovered biological pathways. Recent human genetic association studies have implicated interferon‐gamma inducible protein 16 (IFI16) and absent in melanoma 2 (AIM2) with high periodontal interleukin (IL)‐1β levels and more destructive disease, but mechanistic evidence is lacking. Here, we sought to experimentally validate these observational associations and better understand IFI16 and AIM2's roles in periodontitis. Methods Periodontitis was induced in Ifi204–/– (IFI16 murine homolog) and Aim2–/– mice using the ligature model. Chimeric mice were created to identify the main source cells of Ifi204 in the periodontium. IFI16‐silenced human endothelial cells were treated with periodontal pathogens in vitro. Periodontal tissues from Ifi204–/– mice were evaluated for alveolar bone (micro‐CT), cell inflammatory infiltration (MPO+ staining), Il1b (qRT‐PCR), and osteoclast numbers (cathepsin K+ staining). Results Ifi204‐deficient mice&gt; exhibited &gt;20% higher alveolar bone loss than wild‐type (WT) (P &lt; 0.05), while no significant difference was found in Aim2–/– mice. Ifi204's effect on bone loss was primarily mediated by a nonbone marrow source and was independent of Aim2. Ifi204‐deficient mice had greater neutrophil/macrophage trafficking into gingival tissues regardless of periodontitis development compared to WT. In human endothelial cells, IFI16 decreased the chemokine response to periodontal pathogens. In murine periodontitis, Ifi204 depletion elevated gingival Il1b and increased osteoclast numbers at diseased sites (P &lt; 0.05). Conclusions These findings support IFI16's role as a novel regulator of inflammatory cell trafficking to the periodontium that protects against bone loss and offers potential targets for the development of new periodontal disease biomarkers and therapeutics.</description><identifier>ISSN: 0022-3492</identifier><identifier>EISSN: 1943-3670</identifier><identifier>DOI: 10.1002/JPER.21-0668</identifier><identifier>PMID: 35404474</identifier><language>eng</language><publisher>United States</publisher><subject>Alveolar Bone Loss - genetics ; Alveolar Bone Loss - metabolism ; Alveolar Bone Loss - prevention &amp; control ; Animals ; Biomarkers - metabolism ; Cathepsin K ; Disease Models, Animal ; Endothelial Cells - metabolism ; genetics ; host modulation ; inflammasome ; inflammatory disease ; Interferon-gamma - metabolism ; Interferons - metabolism ; Mice ; Nuclear Proteins - genetics ; Nuclear Proteins - metabolism ; periodontitis ; Periodontitis - genetics ; Periodontitis - metabolism ; Phosphoproteins - genetics ; Phosphoproteins - metabolism</subject><ispartof>Journal of periodontology (1970), 2022-09, Vol.93 (9), p.1366-1377</ispartof><rights>2022 American Academy of Periodontology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3905-1b0039354e345742a8f3882810e8daec3ba53c3cdddcfd6b60546bc068b534fc3</citedby><cites>FETCH-LOGICAL-c3905-1b0039354e345742a8f3882810e8daec3ba53c3cdddcfd6b60546bc068b534fc3</cites><orcidid>0000-0003-0610-3193 ; 0000-0003-3105-0599 ; 0000-0003-1290-7251</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2FJPER.21-0668$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2FJPER.21-0668$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35404474$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Swanson, Karen V.</creatorcontrib><creatorcontrib>Girnary, Mustafa</creatorcontrib><creatorcontrib>Alves, Tomaz</creatorcontrib><creatorcontrib>Ting, Jenny PY</creatorcontrib><creatorcontrib>Divaris, Kimon</creatorcontrib><creatorcontrib>Beck, Jim</creatorcontrib><creatorcontrib>Pucinelli, Carolina Maschietto</creatorcontrib><creatorcontrib>da Silva, Raquel Assed Bezerra</creatorcontrib><creatorcontrib>Uyan, Dilek</creatorcontrib><creatorcontrib>Wilson, Justin E.</creatorcontrib><creatorcontrib>Seaman, William T.</creatorcontrib><creatorcontrib>Webster‐Cyriaque, Jennifer</creatorcontrib><creatorcontrib>Vias, Nishma</creatorcontrib><creatorcontrib>Jiao, Yizu</creatorcontrib><creatorcontrib>Cantley, Lloyd</creatorcontrib><creatorcontrib>Marlier, Arnaud</creatorcontrib><creatorcontrib>Arnold, Roland R.</creatorcontrib><creatorcontrib>Marchesan, Julie T.</creatorcontrib><title>Interferon activated gene 204 protects against bone loss in experimental periodontitis</title><title>Journal of periodontology (1970)</title><addtitle>J Periodontol</addtitle><description>Background Periodontal destruction can be the result of different known and yet‐to‐be‐discovered biological pathways. Recent human genetic association studies have implicated interferon‐gamma inducible protein 16 (IFI16) and absent in melanoma 2 (AIM2) with high periodontal interleukin (IL)‐1β levels and more destructive disease, but mechanistic evidence is lacking. Here, we sought to experimentally validate these observational associations and better understand IFI16 and AIM2's roles in periodontitis. Methods Periodontitis was induced in Ifi204–/– (IFI16 murine homolog) and Aim2–/– mice using the ligature model. Chimeric mice were created to identify the main source cells of Ifi204 in the periodontium. IFI16‐silenced human endothelial cells were treated with periodontal pathogens in vitro. Periodontal tissues from Ifi204–/– mice were evaluated for alveolar bone (micro‐CT), cell inflammatory infiltration (MPO+ staining), Il1b (qRT‐PCR), and osteoclast numbers (cathepsin K+ staining). Results Ifi204‐deficient mice&gt; exhibited &gt;20% higher alveolar bone loss than wild‐type (WT) (P &lt; 0.05), while no significant difference was found in Aim2–/– mice. Ifi204's effect on bone loss was primarily mediated by a nonbone marrow source and was independent of Aim2. Ifi204‐deficient mice had greater neutrophil/macrophage trafficking into gingival tissues regardless of periodontitis development compared to WT. In human endothelial cells, IFI16 decreased the chemokine response to periodontal pathogens. In murine periodontitis, Ifi204 depletion elevated gingival Il1b and increased osteoclast numbers at diseased sites (P &lt; 0.05). Conclusions These findings support IFI16's role as a novel regulator of inflammatory cell trafficking to the periodontium that protects against bone loss and offers potential targets for the development of new periodontal disease biomarkers and therapeutics.</description><subject>Alveolar Bone Loss - genetics</subject><subject>Alveolar Bone Loss - metabolism</subject><subject>Alveolar Bone Loss - prevention &amp; control</subject><subject>Animals</subject><subject>Biomarkers - metabolism</subject><subject>Cathepsin K</subject><subject>Disease Models, Animal</subject><subject>Endothelial Cells - metabolism</subject><subject>genetics</subject><subject>host modulation</subject><subject>inflammasome</subject><subject>inflammatory disease</subject><subject>Interferon-gamma - metabolism</subject><subject>Interferons - metabolism</subject><subject>Mice</subject><subject>Nuclear Proteins - genetics</subject><subject>Nuclear Proteins - metabolism</subject><subject>periodontitis</subject><subject>Periodontitis - genetics</subject><subject>Periodontitis - metabolism</subject><subject>Phosphoproteins - genetics</subject><subject>Phosphoproteins - metabolism</subject><issn>0022-3492</issn><issn>1943-3670</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFvVCEUhYmxsWN159qwdNHXAheYx8bENNXWNGlj1C3h8e4bMW9gBKbafy_TqY1uXMHN-XI43EPIK85OOGPi9OPN-acTwTumdf-ELLiR0IFesqdk0WTRgTTikDwv5XsbuQT2jByCkkzKpVyQr5exYp4wp0idr-HWVRzpCiNSwSTd5FTR10LdyoVYKh1SU-ZUCg2R4q8N5rDGWN1Md9c0plhDDeUFOZjcXPDlw3lEvrw__3x20V1df7g8e3fVeTBMdXxgDExLgyDVUgrXT9D3oucM-9Ghh8Ep8ODHcfTTqAfNlNSDZ7ofFMjJwxF5u_fdbIc1jr5FyW62m5bK5TubXLD_KjF8s6t0a43sjRa6Gbx5MMjpxxZLtetQPM6zi5i2xQrd1qcEGNPQ4z3qc_t_xunxGc7srgq7q8IKbndVNPz139Ee4T-7bwDsgZ9hxrv_mt0PnBml4Dd03pWL</recordid><startdate>202209</startdate><enddate>202209</enddate><creator>Swanson, Karen V.</creator><creator>Girnary, Mustafa</creator><creator>Alves, Tomaz</creator><creator>Ting, Jenny PY</creator><creator>Divaris, Kimon</creator><creator>Beck, Jim</creator><creator>Pucinelli, Carolina Maschietto</creator><creator>da Silva, Raquel Assed Bezerra</creator><creator>Uyan, Dilek</creator><creator>Wilson, Justin E.</creator><creator>Seaman, William T.</creator><creator>Webster‐Cyriaque, Jennifer</creator><creator>Vias, Nishma</creator><creator>Jiao, Yizu</creator><creator>Cantley, Lloyd</creator><creator>Marlier, Arnaud</creator><creator>Arnold, Roland R.</creator><creator>Marchesan, Julie T.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0610-3193</orcidid><orcidid>https://orcid.org/0000-0003-3105-0599</orcidid><orcidid>https://orcid.org/0000-0003-1290-7251</orcidid></search><sort><creationdate>202209</creationdate><title>Interferon activated gene 204 protects against bone loss in experimental periodontitis</title><author>Swanson, Karen V. ; Girnary, Mustafa ; Alves, Tomaz ; Ting, Jenny PY ; Divaris, Kimon ; Beck, Jim ; Pucinelli, Carolina Maschietto ; da Silva, Raquel Assed Bezerra ; Uyan, Dilek ; Wilson, Justin E. ; Seaman, William T. ; Webster‐Cyriaque, Jennifer ; Vias, Nishma ; Jiao, Yizu ; Cantley, Lloyd ; Marlier, Arnaud ; Arnold, Roland R. ; Marchesan, Julie T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3905-1b0039354e345742a8f3882810e8daec3ba53c3cdddcfd6b60546bc068b534fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alveolar Bone Loss - genetics</topic><topic>Alveolar Bone Loss - metabolism</topic><topic>Alveolar Bone Loss - prevention &amp; control</topic><topic>Animals</topic><topic>Biomarkers - metabolism</topic><topic>Cathepsin K</topic><topic>Disease Models, Animal</topic><topic>Endothelial Cells - metabolism</topic><topic>genetics</topic><topic>host modulation</topic><topic>inflammasome</topic><topic>inflammatory disease</topic><topic>Interferon-gamma - metabolism</topic><topic>Interferons - metabolism</topic><topic>Mice</topic><topic>Nuclear Proteins - genetics</topic><topic>Nuclear Proteins - metabolism</topic><topic>periodontitis</topic><topic>Periodontitis - genetics</topic><topic>Periodontitis - metabolism</topic><topic>Phosphoproteins - genetics</topic><topic>Phosphoproteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Swanson, Karen V.</creatorcontrib><creatorcontrib>Girnary, Mustafa</creatorcontrib><creatorcontrib>Alves, Tomaz</creatorcontrib><creatorcontrib>Ting, Jenny PY</creatorcontrib><creatorcontrib>Divaris, Kimon</creatorcontrib><creatorcontrib>Beck, Jim</creatorcontrib><creatorcontrib>Pucinelli, Carolina Maschietto</creatorcontrib><creatorcontrib>da Silva, Raquel Assed Bezerra</creatorcontrib><creatorcontrib>Uyan, Dilek</creatorcontrib><creatorcontrib>Wilson, Justin E.</creatorcontrib><creatorcontrib>Seaman, William T.</creatorcontrib><creatorcontrib>Webster‐Cyriaque, Jennifer</creatorcontrib><creatorcontrib>Vias, Nishma</creatorcontrib><creatorcontrib>Jiao, Yizu</creatorcontrib><creatorcontrib>Cantley, Lloyd</creatorcontrib><creatorcontrib>Marlier, Arnaud</creatorcontrib><creatorcontrib>Arnold, Roland R.</creatorcontrib><creatorcontrib>Marchesan, Julie T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of periodontology (1970)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swanson, Karen V.</au><au>Girnary, Mustafa</au><au>Alves, Tomaz</au><au>Ting, Jenny PY</au><au>Divaris, Kimon</au><au>Beck, Jim</au><au>Pucinelli, Carolina Maschietto</au><au>da Silva, Raquel Assed Bezerra</au><au>Uyan, Dilek</au><au>Wilson, Justin E.</au><au>Seaman, William T.</au><au>Webster‐Cyriaque, Jennifer</au><au>Vias, Nishma</au><au>Jiao, Yizu</au><au>Cantley, Lloyd</au><au>Marlier, Arnaud</au><au>Arnold, Roland R.</au><au>Marchesan, Julie T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interferon activated gene 204 protects against bone loss in experimental periodontitis</atitle><jtitle>Journal of periodontology (1970)</jtitle><addtitle>J Periodontol</addtitle><date>2022-09</date><risdate>2022</risdate><volume>93</volume><issue>9</issue><spage>1366</spage><epage>1377</epage><pages>1366-1377</pages><issn>0022-3492</issn><eissn>1943-3670</eissn><abstract>Background Periodontal destruction can be the result of different known and yet‐to‐be‐discovered biological pathways. Recent human genetic association studies have implicated interferon‐gamma inducible protein 16 (IFI16) and absent in melanoma 2 (AIM2) with high periodontal interleukin (IL)‐1β levels and more destructive disease, but mechanistic evidence is lacking. Here, we sought to experimentally validate these observational associations and better understand IFI16 and AIM2's roles in periodontitis. Methods Periodontitis was induced in Ifi204–/– (IFI16 murine homolog) and Aim2–/– mice using the ligature model. Chimeric mice were created to identify the main source cells of Ifi204 in the periodontium. IFI16‐silenced human endothelial cells were treated with periodontal pathogens in vitro. Periodontal tissues from Ifi204–/– mice were evaluated for alveolar bone (micro‐CT), cell inflammatory infiltration (MPO+ staining), Il1b (qRT‐PCR), and osteoclast numbers (cathepsin K+ staining). Results Ifi204‐deficient mice&gt; exhibited &gt;20% higher alveolar bone loss than wild‐type (WT) (P &lt; 0.05), while no significant difference was found in Aim2–/– mice. Ifi204's effect on bone loss was primarily mediated by a nonbone marrow source and was independent of Aim2. Ifi204‐deficient mice had greater neutrophil/macrophage trafficking into gingival tissues regardless of periodontitis development compared to WT. In human endothelial cells, IFI16 decreased the chemokine response to periodontal pathogens. In murine periodontitis, Ifi204 depletion elevated gingival Il1b and increased osteoclast numbers at diseased sites (P &lt; 0.05). Conclusions These findings support IFI16's role as a novel regulator of inflammatory cell trafficking to the periodontium that protects against bone loss and offers potential targets for the development of new periodontal disease biomarkers and therapeutics.</abstract><cop>United States</cop><pmid>35404474</pmid><doi>10.1002/JPER.21-0668</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-0610-3193</orcidid><orcidid>https://orcid.org/0000-0003-3105-0599</orcidid><orcidid>https://orcid.org/0000-0003-1290-7251</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0022-3492
ispartof Journal of periodontology (1970), 2022-09, Vol.93 (9), p.1366-1377
issn 0022-3492
1943-3670
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9489626
source Wiley-Blackwell Journals; MEDLINE
subjects Alveolar Bone Loss - genetics
Alveolar Bone Loss - metabolism
Alveolar Bone Loss - prevention & control
Animals
Biomarkers - metabolism
Cathepsin K
Disease Models, Animal
Endothelial Cells - metabolism
genetics
host modulation
inflammasome
inflammatory disease
Interferon-gamma - metabolism
Interferons - metabolism
Mice
Nuclear Proteins - genetics
Nuclear Proteins - metabolism
periodontitis
Periodontitis - genetics
Periodontitis - metabolism
Phosphoproteins - genetics
Phosphoproteins - metabolism
title Interferon activated gene 204 protects against bone loss in experimental periodontitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T06%3A57%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interferon%20activated%20gene%20204%20protects%20against%20bone%20loss%20in%20experimental%20periodontitis&rft.jtitle=Journal%20of%20periodontology%20(1970)&rft.au=Swanson,%20Karen%20V.&rft.date=2022-09&rft.volume=93&rft.issue=9&rft.spage=1366&rft.epage=1377&rft.pages=1366-1377&rft.issn=0022-3492&rft.eissn=1943-3670&rft_id=info:doi/10.1002/JPER.21-0668&rft_dat=%3Cproquest_pubme%3E2649252399%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2649252399&rft_id=info:pmid/35404474&rfr_iscdi=true